SCSupapitch Chanthong

Supapitch Chanthong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Supapitch Chanthong has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Oxidative stress and antioxidant capacity in hereditary elliptocytosis and hereditary pyropoikilocytosis

    by Supawadee Maneekesorn, Chane Choed‐Amphai, Supapitch Chanthong, Adisak Tantiworawit, Arunee Phusua, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool, Pimlak Charoenkwan

    Summary: Hereditary elliptocytosis (HE) and hereditary pyropoikilocytosis (HPP) are red blood cell (RBC) membrane disorders caused by defects in spectrin interactions, leading to variable degrees of haemolysis. This study aimed to compare RBC fragility, oxidative stress and antioxidant capacity among individuals with HE, HPP and healthy controls. Blood samples from 15 subjects ( n = 5 per group) were analysed. Chemical‐induced haemolysis assays revealed significantly increased haemolysis in HPP RBCs, whereas haemolysis did not differ between HE and healthy controls. Intracellular reactive oxygen species (ROS) were highest in HPP RBCs under basal and 0.5 mM H 2 O 2 ‐induced conditions. Lipid peroxidation was increased in HPP RBC ghosts under basal conditions and was significantly elevated in plasma compared with both normal and HE groups. Antioxidant enzyme activities (superoxide dismutase [SOD] and glutathione peroxidase [GPx]) were largely comparable among groups, except for increased RBC SOD activity in HPP compared with normal controls. These findings indicate that HPP is characterized by marked membrane instability, elevated oxidative stress and increased lipid peroxidation, while antioxidant capacity remains relatively preserved. Collectively, these abnormalities are likely to contribute to the severe haemolytic phenotype observed in HPP compared with HE and healthy individuals.


  • Revisiting predictors of high-dose methotrexate related severe nephrotoxicity in children with acute lymphoblastic leukemia

    by Chane Choed-Amphai, Jiraporn Khorana, Lalita Sathitsamitphong, Supawadee Maneekesorn, Supapitch Chanthong, Rungrote Natesirinilkul, Pimlak Charoenkwan

    Introduction: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and high-dose methotrexate (HDMTX) is a key chemotherapeutic agent. HDMTX can cause nephrotoxicity. This study aimed to identify prognostic indicators of HDMTX-related severe nephrotoxicity in children with ALL. Methods: A retrospective review of children with ALL treated at Chiang Mai University Hospital (2016–2020) was conducted. Demographic, clinical, and treatment-related factors associated with HDMTX-related severe nephrotoxicity were analyzed using multivariable multilevel logistic regression, reported as adjusted odds ratio (aOR). Results: A total of 61 children with ALL underwent 243 HDMTX infusion cycles. HDMTX-related severe nephrotoxicity occurred in 37.7% (23/61) of patients and 12.3% (30/243) of infusion cycles. No significant differences in baseline characteristics were observed. Concurrent amikacin use was an independent risk factor (aOR = 17.693 [1.613–194.032] P = 0.019), while higher baseline urine pH was protective (aOR = 0.190 [0.082–0.440] P < 0.001). A baseline urine pH < 7.0 was identified as the optimal cutoff for predicting HDMTX-related severe nephrotoxicity (area under the ROC curve = 0.72 [0.63–0.81]). All nephrotoxic events resolved completely. Conclusions: Concurrent amikacin use and low baseline urine pH are significant predictors of HDMTX-related severe nephrotoxicity in children with ALL. Identification of these factors is crucial for preventing nephrotoxicity.